Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Urology|March 5, 2018
Titanized Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-out Single-incision Technique: Minimum 12-Months Follow-up StudyEmilio Sacco, Carlo Gandi, Luigi Vaccarella, et al.Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|March 16, 2023
Determinants of renal papillary appearance in kidney stone formers: An in-depth examinationMatteo Bargagli, Francesco Pinto, Rossella De Leonardis, et al.Journal of Clinical Immunology|April 21, 2020
Urogenital Abnormalities in Adenosine Deaminase DeficiencyRoberta Pajno, Lucia Pacillo, Salvatore Recupero, et al.Brain : a Journal of Neurology|April 26, 2025
Effects of atidarsagene autotemcel gene therapy on peripheral nerves in late-infantile metachromatic leukodystrophyAlberto A Zambon, Paola M V Rancoita, Angelo Quattrini, et al.Journal of Inherited Metabolic Disease|April 15, 2021
Metachromatic leukodystrophy: A single-center longitudinal study of 45 patientsFrancesca Fumagalli, Alberto A Zambon, Paola M V Rancoita, et al.Biomedicines|July 29, 2023
Outcome of BCG Vaccination in ADA-SCID Patients: A 12-Patient SeriesDaniele Canarutto, Chiara Oltolini, Federica Barzaghi, et al.Frontiers in Immunology|July 12, 2023
Hemophagocytic inflammatory syndrome in ADA-SCID: report of two cases and literature reviewElena Sophia Fratini, Maddalena Migliavacca, Federica Barzaghi, et al.Bone Marrow Transplantation|June 1, 2019
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapyFrancesca Tucci, Marta Frittoli, Federica Barzaghi, et al.Science Translational Medicine|May 1, 2024
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndromeGiulia Consiglieri, Francesca Tucci, Maurizio De Pellegrin, et al.Lancet (London, England)|January 23, 2022
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded accessFrancesca Fumagalli, Valeria Calbi, Maria Grazia Natali Sora, et al.Pageof 2